Home Search

Huntington’s Disease - search results

If you're not happy with the results, please do another search

Intramembrane proteases in neurodegenerative diseases

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.
therapeutic intervention

What’s in an aggregate? Therapeutic intervention in Huntington’s

Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
Alzheimer’s

Nanoimaging to cure Alzheimer’s disease

Background of Alzheimer’s disease Alzheimer’s disease (AD) is one of the most devastating neurodegenerative disorders affecting more than 25 million people worldwide which is the fifth leading cause of death for those aged 65 years and above. The disease typically starts with a difficulty to remember new information and as...
North America Analysis

North America Analysis July 2018

Welcome to the packed July 2018 edition of North America Analysis. One of the many insights in this edition comes from the Huntington’s Disease Society of America who explores the sources of funding in the development of therapies for Huntington’s disease (HD) in the U.S. today
Digitally generated image, perfectly usable for all kinds of topics related to digital innovations, AI, data processing, network security or technology and computer science in general.

Flame system: Computerised cognitive assessment for remote brain health monitoring

Monitoring brain health, particularly cognition, in older adults is increasingly recognised as a significant priority for research, healthcare and broader public health. Find out here about the development and validation of the FLAME System, a computerised cognitive assessment for remote brain health monitoring.

C. I. Edvard Smith – Karolinska Institutet (KI)

CIE Smith, MD, PhD, Professor, Dept of Laboratory Medicine, Karolinska Institutet (KI) CIE Smith is professor in molecular genetics at Karolinska Institutet. Smith’s main research interest is cellular signaling, especially protein phosphorylation in lymphocyte development and synthetic oligonucleotide therapies His research group cloned the disease gene, BTK, for X-linked agammaglobulinemia...
neuroscience research, diseases

Understanding the brain: hope for neuroscience research

Advancing neuroscience research improves quality of life for all people with neurological disorders, and ultimately can prevent or cure these diseases. Open Access Government highlight some research priorities in neuroscience.
Ellice Parkinson

Ms Ellice Parkinson – School of Health Sciences University of East Anglia (UEA)

Ellice is a first-year PhD Student undertaking a mixed-methods project investigating low-intake dehydration amongst older adults.
Patients and Public Involvement

Patient and Public Involvement at the heart of brain research

Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
acquired brain injury care, neurorehabilitation

Acquired Brain Injury care undergoes changes in England

Ruth Smith, COO at Christchurch Group, applauds England's 27 Major Trauma Centres provision of rehabilitation prescriptions for Acquired Brain Injury care.
health services

Partnership with patients: The way forward to better and sustainable health service

Astri Arnesen, President of the European Huntington Association argues that building a partnership with patients is the best way forward to promote better and sustainable health services
HTT in gene expression

New functions of HTT in gene expression

Naoko Tanese from New York University explores how monitoring gene expression can be used to treat neurodegenerative diseases such as Huntington's

North America Analysis August 2017

Welcome to the North America Analysis August 2017 edition where we look at a number of key areas within Canada and the US such as healthcare, the environment, and science
brain

Innovative brain imaging

Energy defects, neuroinflammatory processes, and abnormal cellular morphology in neurodegenerative diseases (ND) would constitute extremely informative brain imaging biomarkers of disease progression and readouts in clinical trials. Emerging research aims at developing novel brain imaging methods to study these different aspects not only in animal models but also in...
foetal development stage

How do environmental factors affect foetal development?

Associate Professor Ken Tachibana, discloses how prenatal ambient fine particle exposure disrupts DNA methylation and subsequent gene expression in the foetal development stage.

Follow Open Access Government